Published in Vaccine Weekly, October 11th, 1999
"We found no benefit in routine administration of scorpion antivenom after scorpion sting, irrespective of clinical severity," wrote Fekri Abroug of the intensive care unit of CHU F Bourguiba, Monastir, Tunisia, and colleagues.
Abroug et al. reported the trial data in the journal The Lancet ("Serotherapy in Scorpion Envenomation: A Randomized Controlled Trial," Lancet, 1999; 354:906-9).
The finding is of great importance to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly